SCHEMBL23635971

SCHEMBL23635971

COc1cccc(OC)c1S(=O)(=O)Nc1nnc(-c2cc(Cl)ccc2OC(C)C)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 5/20 0.43
KDM1A O60341 3/20 0.43
MAPT P10636 1/20 0.43
NPC1 O15118 4/20 0.40
HSD17B10 Q99714 3/20 0.40
KDM4E B2RXH2 3/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 1/20 0.39
AMY1A P0DUB6 1/20 0.39
KAT7 O95251 1/20 0.38
KAT6B Q8WYB5 1/20 0.38
KAT6A Q92794 1/20 0.38
KAT5 Q92993 1/20 0.38
KAT8 Q9H7Z6 1/20 0.38
DRD2 P14416 1/20 0.37
ADRA1D P25100 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23292605 0.80 KMT2A (0.48) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL27097756 0.78 KDM4E (0.59) MEN1KMT2AALDH1A1KDM1AMAPT
SCHEMBL23635977 0.77 RXFP1 (0.46) MEN1KMT2AALDH1A1KDM1AMAPT
SCHEMBL23635973 0.76 SCN9A (0.45) MEN1KMT2AALDH1A1NPC1HSD17B10
SCHEMBL23292525 0.74 S1PR1 (0.48) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL23635965 0.73 KDM4E (0.52) MEN1KMT2AALDH1A1KDM1ANPC1
SCHEMBL23635980 0.73 AMY1A (0.50) MEN1KMT2AALDH1A1KDM1AMAPT
SCHEMBL23635961 0.72 KDM4E (0.44) MEN1KMT2AALDH1A1KDM1ANPC1
SCHEMBL23292554 0.71 KDM4E (0.56) ALDH1A1MAPTNPC1HSD17B10KDM4E
SCHEMBL23635987 0.71 RXFP1 (0.44) MEN1KMT2AALDH1A1NPC1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-20210213004-A1 Compounds CTXT PTY LTD (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210213004-A1 Compounds SLC10A1, ABCB11, REN MEN1 114/4885KMT2A 4080/4885ALDH1A1 744/4885
US-11911372-B2 Compounds SLC10A1, ABCB11, REN MEN1 114/4885KMT2A 4080/4885ALDH1A1 744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.